Progen goes into Phase III and ChemGenex Phase II, Bionomics looks at anxiety, Clinuvel gets orphan designation and Avexa announces collaboration and good results. [ + ]

Planetary scientist asks the question: should we expect extraterrestrials to be as stupid as we are? [ + ]

Thermo Fisher Scientific has opened a state-of-the-art facility in Adelaide, SA.

Turkish researchers have conducted a small clinical trial of breast cancer drug tamoxifen in people with bipolar disorder. [ + ]

Blood platelet protein regulates serotonin transporter and determines blood serotonin levels. [ + ]

C. elegans caps its chromosomes with a G-tail off the right and a C-tail off the left. [ + ]

Two papers by WAIMR scientists unlock how genes and hormones contribute to red blood cell formation. [ + ]

UQ researchers are developing a predictive test for type 1 diabetes by tracing activation of the NF-kappa B pathway. [ + ]

What's New in LAB Technology editor Janette Woodhouse reports on the Australian contingent at Pittcon 2008.

Elizabeth Blackburn accepts her L'Oreal women in science award in Paris. [ + ]

More effective treatments for brain cancer will be developed at a tumour-cell testing facility opened yesterday at The University of Queensland’s Queensland Brain Institute.

Many companies release their latest products at Pittcon. This year, as part of the swing away from biotechnology and towards environmental sustainability testing, there is an abundance of bio-diesel and bio-fuel analysers hitting the market.

US researchers discover how certain proteins control the process of programmed cell death. [ + ]

Biotechnology seems to have taken a back seat this year at Pittcon, the huge annual laboratory conference and exposition held in the US.

US researchers design artificial antigen-presenting cells to boost T cell proliferation. [ + ]